We are live on
!
Find out more
Boothbay Fund Management Portfolio holdings
AUM
$7.6B
Turnover
48.76%
1-Year Est. Return
109.3%
This Fund
S&P 500
This Quarter
Est. Return
+7.95%
1 Year Est. Return
+109.3%
3 Year Est. Return
+327.81%
5 Year Est. Return
+375.31%
10 Year Est. Return
+1,905.24%
AUM
$7.71B
AUM Growth
+$1.01B
(+15%)
Cap. Flow
+$386M
Cap. Flow
% of AUM
5.01%
Top 10 Holdings %
Top 10 Hldgs %
31.27%
Holding
2,619
New
714
Increased
625
Reduced
461
Closed
609
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.6
years
Top 20 Avg Time Held Equity + Options
0.6
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.5
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cornerstone Strategic Value Fund
CLM
|
+$42.9M |
| 2 |
GE Aerospace
GE
|
+$30M |
| 3 |
Kratos Defense & Security Solutions
KTOS
|
+$27.9M |
| 4 |
Sable Offshore Corp
SOC
|
+$17.1M |
| 5 |
Prologis
PLD
|
+$16.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$26.3M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$23.7M |
| 3 |
TSMC
TSM
|
+$20.7M |
| 4 |
Cidara Therapeutics
CDTX
|
+$17.6M |
| 5 |
NVIDIA
NVDA
|
+$16.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.29% |
| 2 | Technology | 9.41% |
| 3 | Healthcare | 9.32% |
| 4 | Consumer Discretionary | 7.11% |
| 5 | Industrials | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
CALL
AT&T
T
$161B
| $1.37B | 17.81% |
+47,400,000
| New | +$1.27B |
2026 Q1
0 quarters
|
|
|
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$813B
| $418M | 5.41% |
642,100
+492,100
| +328% | +$335M |
2025 Q1
4 quarters
|
|
|
3
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$813B
| $283M | 3.67% |
435,700
-828,000
| -66% | -$563M |
2014 Q4
45 quarters
|
|
4
PUT
iShares Russell 2000 ETF
IWM
$77B
| $53.1M | 0.69% |
+214,000
| New | +$55.2M |
2026 Q1
0 quarters
|
|
5
Abivax
ABVX
$7.97B
| $52.7M | 0.68% |
472,961
-34,920
| -7% | -$4.13M |
2024 Q4
5 quarters
|
|
|
6
Cornerstone Strategic Value Fund
CLM
$1.95B
| $49.1M | 0.64% |
6,744,553
+5,459,213
| +425% | +$42.9M |
2022 Q3
14 quarters
|
|
7
CALL
Tesla
TSLA
$1.42T
| $46.8M | 0.61% |
126,000
+27,100
| +27% | +$11.2M |
2025 Q3
2 quarters
|
|
8
Amazon
AMZN
$2.74T
| $45.5M | 0.59% |
218,663
+39,090
| +22% | +$8.61M |
2016 Q2
39 quarters
|
|
9
CALL
Microsoft
MSFT
$4.01T
| $45.3M | 0.59% |
122,300
+74,400
| +155% | +$31.1M |
2024 Q4
5 quarters
|
|
10
CALL
Invesco KBW Bank ETF
KBWB
$6.18B
| $44.9M | 0.58% |
+568,000
| New | +$47.5M |
2026 Q1
0 quarters
|
|
11
CALL
United Therapeutics
UTHR
$23.5B
| $44.8M | 0.58% |
+75,600
| New | +$37.7M |
2026 Q1
0 quarters
|
|
12
Revolution Medicines
RVMD
$40.7B
| $42.7M | 0.55% |
438,595
+111,443
| +34% | +$11.3M |
2025 Q1
4 quarters
|
|
13
Equinix
EQIX
$97B
| $42.3M | 0.55% |
43,158
-13,048
| -23% | -$11.6M |
2023 Q1
12 quarters
|
|
14
Seagate
STX
$153B
| $36.5M | 0.47% |
93,275
+17,807
| +24% | +$6.79M |
2024 Q3
6 quarters
|
|
|
15
PUT
Revolution Medicines
RVMD
$40.7B
| $35.2M | 0.46% |
+361,900
| New | +$36.5M |
2026 Q1
0 quarters
|
|
16
Exelixis
EXEL
$15.5B
| $34.5M | 0.45% |
803,866
-183
| -0% | -$7.87K |
2023 Q1
12 quarters
|
|
17
PUT
Invesco QQQ Trust
QQQ
$484B
| $32.6M | 0.42% |
56,400
-295,100
| -84% | -$179M |
2022 Q4
13 quarters
|
|
|
18
NVIDIA
NVDA
$5.24T
| $30.9M | 0.4% |
177,153
-91,410
| -34% | -$16.8M |
2019 Q4
25 quarters
|
|
19
Vaxcyte
PCVX
$10.2B
| $30.3M | 0.39% |
522,019
+24,279
| +5% | +$1.32M |
2025 Q1
4 quarters
|
|
20
SBA Communications
SBAC
$19.3B
| $29.6M | 0.38% |
172,012
-9,769
| -5% | -$1.83M |
2022 Q4
13 quarters
|
|
|
21
GE Aerospace
GE
$321B
| $29.4M | 0.38% |
103,753
+95,503
| +1,158% | +$30M |
2025 Q1
4 quarters
|
|
22
CALL
Apple
AAPL
$5T
| $27.7M | 0.36% |
109,200
+6,200
| +6% | +$1.61M |
2024 Q4
5 quarters
|
|
23
Mineralys Therapeutics
MLYS
$1.89B
| $27.1M | 0.35% |
1,001,728
+9,646
| +1% | +$283K |
2024 Q2
7 quarters
|
|
|
24
CALL
iShares Russell 2000 ETF
IWM
$77B
| $25.9M | 0.34% |
+104,400
| New | +$26.9M |
2026 Q1
0 quarters
|
|
25
DELISTED
Terns Pharmaceuticals
TERN
| $25.6M | 0.33% |
486,170
+39,162
| +9% | +$1.61M |
2022 Q2
15 quarters
|
|
Similar funds
Boothbay Fund Management's Q1 2026 Portfolio in Review
As of Q1 2026, Boothbay Fund Management held 2,619 positions worth $7.71B, up 15% from $6.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Boothbay Fund Management deployed $386M of net new capital in Q1 2026, opening 714 new positions and adding to 625 existing holdings. Its largest new stake was Kratos Defense & Security Solutions: 290,936 shares worth $20.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 46% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $26.3M trimmed.
- Boothbay Fund Management's largest Q1 2026 buy was Kratos Defense & Security Solutions: 290,936 shares worth $20.5M.
- Boothbay Fund Management added most to Cornerstone Strategic Value Fund in Q1 2026, an estimated $42.9M increase.
- Boothbay Fund Management's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $26.3M.
- Boothbay Fund Management fully exited Cidara Therapeutics in Q1 2026, selling an estimated $17.6M.
- Boothbay Fund Management's ten largest holdings make up 31% of its $7.71B portfolio in Q1 2026.
- Boothbay Fund Management opened 714 new positions and closed 609 in Q1 2026.
- Boothbay Fund Management's portfolio value rose 15% quarter-over-quarter to $7.71B.
Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.